ADVERTISEMENT

Conference Report

ENDO 2022 — Nonstatin therapies for lowering LDL-C: new kids on the block

Drishti Agarwal   |   21 June 2022

In a plenary session at ENDO 2022 titled “Novel nonstatin therapies for LDL cholesterol lowering,” chaired by Anne Goldberg, MD, FACP, and Lisa Tannock, MD, several experts discussed the current clinical status of novel nonstatin, low-density lipoprotein cholesterol   (LDL-C)-lowering agents.

PCSK9 inhibitors (John Stafford, Vanderbilt University Medical Center, Tennessee)

Dr Stafford’s...

          

November Challenge

Ends in 1d 6h
left
right

Topic Challenges

left
right